A detailed history of State Of Michigan Retirement System transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, State Of Michigan Retirement System holds 371,843 shares of GILD stock, worth $34.4 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
371,843
Previous 373,943 0.56%
Holding current value
$34.4 Million
Previous $25.7 Million 21.48%
% of portfolio
0.16%
Previous 0.13%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$66.59 - $83.99 $139,839 - $176,379
-2,100 Reduced 0.56%
371,843 $31.2 Million
Q2 2024

Jul 26, 2024

BUY
$63.15 - $72.88 $309,435 - $357,112
4,900 Added 1.33%
373,943 $25.7 Million
Q1 2024

Apr 18, 2024

BUY
$71.58 - $87.29 $21,474 - $26,187
300 Added 0.08%
369,043 $27 Million
Q4 2023

Jan 22, 2024

SELL
$73.27 - $83.09 $139,213 - $157,871
-1,900 Reduced 0.51%
368,743 $29.9 Million
Q3 2023

Oct 27, 2023

SELL
$73.94 - $80.67 $502,792 - $548,556
-6,800 Reduced 1.8%
370,643 $27.8 Million
Q2 2023

Jul 26, 2023

BUY
$76.01 - $86.7 $395,252 - $450,840
5,200 Added 1.4%
377,443 $29.1 Million
Q1 2023

Apr 28, 2023

BUY
$77.31 - $88.08 $115,965 - $132,120
1,500 Added 0.4%
372,243 $30.9 Million
Q4 2022

Jan 27, 2023

SELL
$62.32 - $89.47 $81,016 - $116,311
-1,300 Reduced 0.35%
370,743 $0
Q3 2022

Oct 24, 2022

BUY
$59.54 - $68.01 $47,632 - $54,408
800 Added 0.22%
372,043 $23 Million
Q2 2022

Aug 08, 2022

SELL
$57.72 - $65.01 $88.5 Million - $99.6 Million
-1,532,500 Reduced 80.5%
371,243 $22.9 Million
Q1 2022

May 04, 2022

BUY
$57.92 - $72.58 $34.8 Million - $43.6 Million
600,635 Added 46.09%
1,903,743 $113 Million
Q4 2021

Jan 27, 2022

BUY
$64.88 - $73.64 $11.1 Million - $12.6 Million
171,748 Added 15.18%
1,303,108 $94.6 Million
Q3 2021

Oct 27, 2021

SELL
$67.69 - $73.03 $31.5 Million - $34 Million
-465,500 Reduced 29.15%
1,131,360 $79 Million
Q2 2021

Jul 27, 2021

BUY
$63.47 - $69.35 $29.5 Million - $32.2 Million
464,300 Added 41.0%
1,596,860 $110 Million
Q1 2021

May 03, 2021

BUY
$60.0 - $68.46 $6,000 - $6,845
100 Added 0.01%
1,132,560 $73.2 Million
Q4 2020

Feb 01, 2021

BUY
$56.65 - $64.55 $44.8 Million - $51.1 Million
791,200 Added 231.85%
1,132,460 $66 Million
Q3 2020

Oct 26, 2020

BUY
$62.1 - $78.08 $1.3 Million - $1.64 Million
21,000 Added 6.56%
341,260 $21.6 Million
Q2 2020

Jul 29, 2020

SELL
$72.34 - $84.0 $35.1 Million - $40.8 Million
-485,664 Reduced 60.26%
320,260 $24.6 Million
Q1 2020

May 01, 2020

BUY
$62.63 - $80.22 $46.7 Million - $59.8 Million
745,673 Added 1237.61%
805,924 $60.3 Million
Q1 2020

Apr 28, 2020

SELL
$62.63 - $80.22 $48.6 Million - $62.3 Million
-776,236 Reduced 92.8%
60,251 $4.5 Million
Q4 2019

Jan 24, 2020

BUY
$61.62 - $67.78 $4.82 Million - $5.3 Million
78,198 Added 10.31%
836,487 $54.4 Million
Q3 2019

Oct 22, 2019

BUY
$62.51 - $69.0 $6,251 - $6,900
100 Added 0.01%
758,289 $48.1 Million
Q2 2019

Jul 26, 2019

SELL
$61.87 - $69.38 $3.91 Million - $4.38 Million
-63,200 Reduced 7.69%
758,189 $51.2 Million
Q1 2019

May 06, 2019

SELL
$62.53 - $70.05 $59.9 Million - $67.1 Million
-958,495 Reduced 53.85%
821,389 $53.4 Million
Q4 2018

Feb 01, 2019

SELL
$60.54 - $79.0 $40.5 Million - $52.9 Million
-669,576 Reduced 27.34%
1,779,884 $111 Million
Q3 2018

Oct 26, 2018

SELL
$71.28 - $78.92 $125 Million - $139 Million
-1,760,264 Reduced 41.81%
2,449,460 $189 Million
Q2 2018

Aug 08, 2018

SELL
$64.88 - $75.68 $45,416 - $52,976
-700 Reduced 0.02%
4,209,724 $298 Million
Q1 2018

May 08, 2018

BUY
$72.84 - $88.8 $109 Million - $133 Million
1,502,700 Added 55.5%
4,210,424 $317 Million
Q4 2017

Feb 01, 2018

BUY
$71.15 - $83.52 $46.5 Million - $54.5 Million
653,000 Added 31.78%
2,707,724 $194 Million
Q3 2017

Oct 19, 2017

BUY
$72.11 - $85.47 $148 Million - $176 Million
2,054,724
2,054,724 $166 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track State Of Michigan Retirement System Portfolio

Follow State Of Michigan Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Michigan Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Of Michigan Retirement System with notifications on news.